Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Bristol-Myers Squibb
Canadian Cancer Trials Group
Bristol-Myers Squibb
Regeneron Pharmaceuticals
Rigshospitalet, Denmark
M.D. Anderson Cancer Center
Alpha Biopharma (Jiangsu) Co., Ltd.
SWOG Cancer Research Network
Second Affiliated Hospital of Guangzhou Medical University
Laibin People's Hospital
Canadian Cancer Trials Group
Fudan University
University of California, San Francisco
University Hospital, Brest
Canadian Cancer Trials Group
University of Wisconsin, Madison
University College, London
Washington University School of Medicine
Guangdong Association of Clinical Trials
European Organisation for Research and Treatment of Cancer - EORTC
Kyunghee University Medical Center
AHS Cancer Control Alberta
Synta Pharmaceuticals Corp.
National Taiwan University Hospital
The Miriam Hospital
Peking University Third Hospital
PIMERIndia
Transgene
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Auron Healthcare GmbH
Zhejiang Cancer Hospital
Memorial Sloan Kettering Cancer Center
The University of Texas Health Science Center at San Antonio
Pierian Biosciences
Bioven Sdn. Bhd.
Sanofi